5-Bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one

Catalog No.: 
ACCBSE346
CAS No.: 
1388071-05-3
Molecular Formula: 
C6H4BrN3O
Molecular Weight: 
214.02
5-Bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%
100mg98%
1g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one
IUPAC Name5-Bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one
Molecular FormulaC6H4BrN3O
Molecular Weight214.02
SMILESO=C1NC2=NC(Br)=CC=C2N1
InChI KeyIZKDVNRPFNMLSZ-UHFFFAOYSA-N
Synonym5-Bromo-1,3-dihydro-imidazo[4,5-b]pyridin-2-one;5-bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one;5-Bromo-1H-imidazo[4,5-b]pyridin-2-ol;2H-Imidazo[4,5-b]pyridin-2-one, 5-bromo-1,3-dihydro-;5-Bromo-1H,2H,3H-imidazo[4,5-b]pyridin-2-one
CAS No.1388071-05-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCBSE346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFVBE375 route compound structure diagram
    ACFVBE375129012-04-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCBSE346 route product structure diagram
    ACCBSE3461388071-05-3
Inquiry

2. ACCBSE346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCBSE346 route product structure diagram
    ACCBSE3461388071-05-3
Inquiry

3. ACCBSE346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCBSE346 route product structure diagram
    ACCBSE3461388071-05-3
Inquiry

Comments (0)